{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:26:59Z","timestamp":1769603219793,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Orthopaedic Science"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00776-012-0294-9","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T07:47:27Z","timestamp":1349077647000},"page":"770-774","source":"Crossref","is-referenced-by-count":14,"title":["Zoledronic acid enhances the effect of radiotherapy for bone metastases from renal cell carcinomas: more than a 24-month median follow-up"],"prefix":"10.1016","volume":"17","author":[{"given":"Naoki","family":"Takeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Isu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Hiraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s00776-012-0294-9_bb0010","first-page":"142","article-title":"Prognosis in renal cell carcinoma: analysis of clinical course following nephrectomy","volume":"19","author":"Tobisu","year":"1989","journal-title":"Jpn J Clin Oncol."},{"key":"10.1007\/s00776-012-0294-9_bb0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.eururo.2006.10.060","article-title":"Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone","volume":"52","author":"Toyada","year":"2007","journal-title":"Eur Urol."},{"key":"10.1007\/s00776-012-0294-9_bb0020","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2106\/JBJS.F.00603","article-title":"Patients survival after for osseous metastases from renal cell carcinoma","volume":"89","author":"Lin","year":"2007","journal-title":"J Bone Joint Surg Am."},{"key":"10.1007\/s00776-012-0294-9_bb0025","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.juro.2010.12.037","article-title":"Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors?","volume":"185","author":"Kume","year":"2011","journal-title":"J Urol."},{"key":"10.1007\/s00776-012-0294-9_bb0030","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0360-3016(85)90223-8","article-title":"Intrinsic radiosensitivity of human cell lines is correlated with radio responsiveness of human tumors: analysis of 101 published survival curves","volume":"11","author":"Fertil","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1007\/s00776-012-0294-9_bb0035","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0936-6555(03)00164-X","article-title":"The effect of biological effective dose on time to symptom progression in metastatic renal cell carcinoma","volume":"15","author":"Wilson","year":"2003","journal-title":"Clin Oncol."},{"key":"10.1007\/s00776-012-0294-9_bb0040","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/cncr.21410","article-title":"A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma","volume":"104","author":"Lee","year":"2005","journal-title":"Cancer."},{"key":"10.1007\/s00776-012-0294-9_bb0045","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0022-5347(01)64305-2","article-title":"Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model","volume":"158","author":"DiBiase","year":"1997","journal-title":"J Urol."},{"key":"10.1007\/s00776-012-0294-9_bb0050","first-page":"377","article-title":"Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial","volume":"7","author":"Rosen","year":"2001","journal-title":"Cancer J."},{"key":"10.1007\/s00776-012-0294-9_bb0055","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/cncr.11701","article-title":"Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial","volume":"98","author":"Rosen","year":"2003","journal-title":"Cancer."},{"issue":"16","key":"10.1007\/s00776-012-0294-9_bb0060","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2003.04.105","article-title":"Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial\u2014the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group","volume":"21","author":"Rosen","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.1007\/s00776-012-0294-9_bb0065","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/cncr.23775","article-title":"Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases","volume":"113","author":"Hatoum","year":"2008","journal-title":"Cancer."},{"key":"10.1007\/s00776-012-0294-9_bb0070","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/cncr.11571","article-title":"Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma","volume":"98","author":"Lipton","year":"2003","journal-title":"Cancer."},{"key":"10.1007\/s00776-012-0294-9_bb0075","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1464-410X.2008.08124.x","article-title":"Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate","volume":"103","author":"Kijima","year":"2009","journal-title":"BJU Int."},{"key":"10.1007\/s00776-012-0294-9_bb0080","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jso.20949","article-title":"Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and micro architecture in a mouse model of tumor-induced osteolysis","volume":"97","author":"Arrington","year":"2008","journal-title":"J Surg Oncol."},{"key":"10.1007\/s00776-012-0294-9_bb0085","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1158\/1535-7163.MCT-07-0311","article-title":"Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma","volume":"6","author":"Scavelli","year":"2007","journal-title":"Mol Cancer Ther."},{"key":"10.1007\/s00776-012-0294-9_bb0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00774-010-0162-7","volume":"28","author":"Yoneda","year":"2010","journal-title":"J Bone Miner Metab."}],"container-title":["Journal of Orthopaedic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265815305856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265815305856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00776-012-0294-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T11:53:58Z","timestamp":1542714838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0949265815305856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0949265815305856"],"URL":"https:\/\/doi.org\/10.1007\/s00776-012-0294-9","relation":{},"ISSN":["0949-2658"],"issn-type":[{"value":"0949-2658","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}